secwatch.observer — SEC 8-K summary
======================================

Issuer:     Teladoc Health, Inc. (TDOC)
CIK:        0001477449
Form:       8-K
Filed at:   2026-04-29T23:59:59+00:00
Accession:  0001477449-26-000026
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud

Teladoc Health Q1 2026 Revenue Falls 2% to $613.8M, Net Loss Narrows to $63.8M
------------------------------------------------------------------------------

- First Quarter 2026 revenue of $613.8 million, down 2% year-over-year
- Net loss improved to $63.8 million ($0.36 per share) from $93.0 million ($0.53 per share) in prior year
- Adjusted EBITDA was $58.2 million, essentially flat year-over-year
- Integrated Care segment revenue up 2% to $395.4 million; BetterHelp down 9% to $218.4 million
- Company reaffirmed full-year 2026 outlook with revenue range $2.481B-$2.576B and adjusted EBITDA $267M-$306M

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477449/000147744926000026/0001477449-26-000026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477449/000147744926000026/tdoc-20260429.htm
  HTML page:      https://secwatch.observer/filing/0001477449-26-000026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer